Cancer Research Technology Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 33

Professionals

  • Investments
  • 77

  • Portfolio
  • 36

  • Exits
  • 34

Exits

Cancer Research Technology General Information

Company Description

Founded in 1982, Cancer Research Horizons is a venture capital firm based in London, United Kingdom. The firm seeks to invest in companies operating in the therapeutics, diagnostics, medtech, drug discovery, vaccines, artificial intelligence, medical devices, software, and healthcare sectors across the United Kingdom.

Business Details

Formerly Known As
Cancer Research Campaign Technology Limited, Restrose Limited, Carlton Medical Products Limited
Year Founded
1982
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 2 Redman Place
  • London E20 1JQ
  • England, United Kingdom
+44 020

Cancer Research Technology Investments (77)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Alethio Therapeutics 05-Nov-2026 Later Stage VC Drug Discovery Clinical Trials - General
52North 29-Sep-2026 Diagnostic Equipment Generating Revenue
Laigo Bio 20-Mar-2026 Drug Discovery Generating Revenue
ALTx Therapeutics 05-Feb-2026 Drug Discovery Startup
Infinitopes 30-Jan-2026 Drug Discovery Clinical Trials - Phase 2
Verinnogen 22-Dec-2025 Discovery Tools (Healthcare) Pre-Clinical Trials
Trogenix 06-Oct-2025 Drug Discovery Pre-Clinical Trials
Alceus Bio 01-Jul-2025 Drug Discovery Startup
AiM Medical Robotics 04-Jun-2025 Later Stage VC Surgical Devices Generating Revenue
Béa Fertility 16-May-2025 Later Stage VC Therapeutic Devices Generating Revenue
You’re viewing 10 of 77 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cancer Research Technology Exits (34)

Company Name Exit Date Exit Type Exit Size
Myricx Bio 28-Aug-2026 Merger/Acquisition
Súil Vision 23-Apr-2026
SynPixels 24-Dec-2025
Oxomics 23-Sep-2025
Stroma Biosciences 25-Feb-2025
Chroma Therapeutics 02-Jul-2024
Metabomed 08-Feb-2024
Arquer Diagnostics 02-Jan-2024
Karus Therapeutics 18-Dec-2023 Bankruptcy: Liquidation
Macrophage Pharma 05-Dec-2023 Bankruptcy: Liquidation
You’re viewing 10 of 34 exits. Get the full list »

Cancer Research Technology Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Cancer Research Technology Co-Investors (95)

Name With Exits Lead Partner Series Industry
Meltwind Advisory 3 Series chart Industry bar
Wilbe Capital Series chart Industry bar
Cambridge Angels Series chart Industry bar
Lilly USA Series chart Industry bar
Sofinnova Partners Series chart Industry bar
You’re viewing 5 of 95 co-investors. Get the full list »

Cancer Research Technology Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Cancer Research Ventures London, United Kingdom 1998

Cancer Research Technology FAQs

  • What is Cancer Research Technology?

    Founded in 1982, Cancer Research Horizons is a venture capital firm based in London, United Kingdom.

  • When was Cancer Research Technology founded?

    Cancer Research Technology was founded in 1982.

  • Where is Cancer Research Technology headquartered?

    Cancer Research Technology is headquartered in London, United Kingdom.

  • What is Cancer Research Technology's total asset value?

    Cancer Research Technology has around in total assets under management.

  • How many investments has Cancer Research Technology made?

    Cancer Research Technology has made 77 investments.

  • What has Cancer Research Technology invested in?

    Cancer Research Technology has made numerous investments in companies like Alethio Therapeutics, 52North, and Laigo Bio within the Drug Discovery and Diagnostic Equipment industries.

  • What has Cancer Research Technology invested in recently?

    Cancer Research Technology's latest investment was on 05-Nov-2026 in Alethio Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process